Bausch Health Co. Inc. (BHC) Reports Q1 Loss of $0.55/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Bausch Health Announces First-Quarter 2023 Results
May 4, 2023 7:01 AM EDTFirst-Quarter revenues of $1.94 billion, up 1% reported and 4% organic1Solid revenue growth across core products, led by Xifaxan with 7% reported growthMid- and late-stage product pipeline advancingBausch Health provides consolidated full-year guidance, and Bausch Health (excl. B+L) confirms 2023 guidance
LAVAL, QC / ACCESSWIRE / May 4, 2023 / Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its first-quarter 2023 financial... More
